Global sample preparation market size is expected to reach $12.79 bn by 2028 at a rate of 8.1% segmented as by product, sample preparation instruments, consumables, sample preparation kit
The global nucleic acid labeling market size was USD 2.16 billion in 2022 and is expected to reach USD 4.32 billion in 2032, and register a revenue CAGR of 8% during the forecast period. Rising demand for personalized medicine, Genomics research, and improvements in Molecular Diagnostics are major factors driving the market revenue growth. To visualize and analyze Gene Expression, protein interactions, and other biological processes, nucleic acids must be labeled with fluorescent, radioactive, or other tags. This is known as nucleic acid labeling.
Global proteomics market is growing at a CAGR of 14.24%, and is expected to reach $91.52 billion during the forecast period, 2022-2030. Get Free Sample Report
In 2022, the global revenue generated by the proteomics market reached approximately US$ 30.8 billion, and it is anticipated to exhibit a robust compound annual growth rate (CAGR) of 17.6%, projecting a valuation of US$ 181.5 billion by the conclusion of 2033. According to the evaluation conducted by Persistence Market Research, the reagents and kits segment is poised to dominate with the highest market value, reaching US$ 18.4 billion by 2023. Contributing to around 6.0% of the total revenue in the global omics market, valued at approximately US$ 514.3 billion by the close of 2022, sales in the proteomics market demonstrate a substantial presence. Over the past eight years, from 2014 to 2022, the global proteomics market has exhibited a historic CAGR of 15.5%.
A recent report published by TheBusinessResearchCompany on Proteomics Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/3a6Fm9E
Analytical standards are the special rules to check the product quality, efficiency and purity of the drug being produced by several pharma companies. They help to achieve the targets set by the manufacturers and used to achieve that optimal growth.
The biochip market is expected to witness significant growth throughout the forecast period because of an increasing application of biochips in genomics, proteomics and drug discovery.
Pancreatic Cancer Market, [By Cancer Type (Squamous Carcinoma, Adenosquamous Carcinoma, Adenocarcinoma); By Diagnosis Type (Blood Test, Biopsy, Biological Markers); By Therapeutic Type (Radiation Therapy, Chemotherapy, Targeted Therapy, Surgery); By End Use (Hospital, Oncology Institutes, Diagnostic Centres)]; and Geography - Trend, Analysis and Forecast
Market Research Future (MRFR) has published a report stating that the global cell viability market is marked to expand at a CAGR of 9.2% during the forecast period of 2018-2023
Proteomics Market, [By Technology Type (Electrophoresis, Microarray, X-Ray Crystallography, Spectroscopy, Surface Plasma Resonance Systems Protein Fractionation Systems, Chromatography), By Product Type (Instruments, Services, Reagents), By Application (Clinical Diagnostics, Drug Discovery)]; and Geography - Trend, Analysis and Forecast
The report Life Science Tools Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Global custom shoes market size is expected to reach $3.75 Bn by 2028 at a rate of 10.4%, segmented as by product type, athletic, non-athletic, safety, formal, casual, other products
The global sample preparation market size will grow from $8.11 billion in 2022 to $8.66 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%.
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
Global research antibodies and reagents market size is expected to reach $24.04 Bn by 2028 at a rate of 10.0%, segmented as by technology, western blot, immunofluorescence, immunohistochemistry, flow cytometry,
According to the latest research report by IMARC Group, The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032. More Info:- https://www.imarcgroup.com/womens-health-diagnostics-market
According to the latest research report by IMARC Group, The global biomarkers market size reached US$ 79.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 220.7 Billion by 2032, exhibiting a growth rate (CAGR) of 11.37% during 2024-2032. More Info:- https://www.imarcgroup.com/biomarkers-market
According to the latest research report by IMARC Group, The global cancer biomarkers market size reached US$ 27.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 77.0 Billion by 2032, exhibiting a growth rate (CAGR) of 11.7% during 2024-2032. More Info:- https://www.imarcgroup.com/cancer-biomarkers-market
The global molecular weight marker market was estimated at a value $265.36 million in 2014. This market is expected to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019.
According to the latest research report by IMARC Group, The United States neurological biomarkers market size is projected to exhibit a growth rate (CAGR) of 4.20% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-neurological-biomarkers-market
According to the latest research report by IMARC Group, The global biobanking market size reached US$ 57.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.86% during 2023-2028. More Info:- https://www.imarcgroup.com/biobanking-market
The growing number of clinical trials and the increasing adoption of immunoassay techniques are among the primary factors driving the cancer/tumor profiling market Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/cancer-tumor-profiling-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The global molecular weight marker market was estimated at a value $265.36 million in 2014. This market is expected to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019.
According to the latest research report by IMARC Group, The global biosensors market size reached US$ 26.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 43.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028. More Info:- https://www.imarcgroup.com/biosensors-market
The global mass spectrometry market size reached USD 4.36 Billion in 2021 and is expected to register a revenue CAGR of 6.1% during the forecast period, according to latest analysis by Emergen Research. Increased spending by pharmaceutical companies on research & development activities is a major factor driving market revenue growth. These research activities are also facilitating developments and drawing in investments in biopharmaceutical and personalized medicine.
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 634.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,064.8 Million by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
The global biobanking market size reached US$ 57.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.86% during 2023-2028.
The new business report on the "High throughput screening market" published by whipsmartmi.com is forecasted to see significant growth during the forecast period
The plasma fractionation market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028.
According to the latest research report by IMARC Group, The global cancer biomarkers market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028. More Info:- https://www.imarcgroup.com/cancer-biomarkers-market
Major players in the bioinformatics market are Agilent Technologies, Illumina, QIAGEN, Affymetrix and Thermo Fisher Scientific... @ https://bit.ly/3hE7KFA
According to the latest research report by IMARC Group, The global blood culture test market size reached US$ 4.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028. More Info:- https://www.imarcgroup.com/blood-culture-test-market
Major players in the Proteomics Market are Danaher Corporation, Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Inc, PerkinElmer, Inc. Read More @ http://bit.ly/3c0NjQq
Global Health Information Systems (HIS) Market Report 2019 explores future trends for supply, demand and market growth rate, market size, prices, trading, competition and value chain as well as Key Players of the industry’s information with forecast from 2019 to 2023.
Major players in the bioinformatics market are Agilent Technologies, Illumina, QIAGEN, Affymetrix and Thermo Fisher Scientific....@ @ https://bit.ly/3hE7KFA
The neurological biomarker market is expected to reach US$ 14,454.7 million by 2027 from US$ 5,501.8 million in 2019. The market is estimated to grow at a CAGR of 13.0% from 2020 to 2027.
According to the latest research report by IMARC Group, The global protein detection & quantification market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.2% during 2023-2028. More Info:- https://www.imarcgroup.com/protein-detection-quantification-market
A recent report published by The Business Research Company on Proteomics Market provides in-depth analysis of segments and sub-segments in the global as well as regional.
The Business Research Company offers research antibodies and reagents market research report 2023 with industry size, share, segments and market growth https://bit.ly/3GNrIvE
Ion chromatography mass spectrometry market offers wide applications in food, pharmaceutical, biotechnology industries helps in process validation and clinical testing of protein identification and quantitative analysis of drugs, pharmacokinetics, proteomics, biomarker discovery, food nutritional composition testing, environment testing and others. Wide application and demand of mass spectrometry in drug discovery have augmented the market growth.
The major players in the sample preparation market are Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, Illumina, Qiagen NV, PerkinElmer, F Hoffman La Roche,... @ @ https://bit.ly/2V4HRb0
Major players in the laboratory automation systems market are Tecan Group, Perkinelmer, Thermo Fisher Scientific, Agilent Technologies, and Danaher..... @ https://bit.ly/31WBxlq